1ChangTT,LaiCL,LiawYF,et al.Incremental in-creases inHBeAgSerovconversion and continuedALT normalization inAsian chronicHBV (CHB)patients treated with lamivudine for four years (abstract). AntiviralTherapy . 2000
2Ono SK,Kato N,Shiratori Y,et al.The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance. Journal of Clinical Investigation, The . 2001
3Pichoud C,Seigneres B,Wang Z,et al.Transient selection of a hepatitis B virus polymerase gene mutant associated with a decreased replication capacity and famciclovir resistance. Hepatology . 1999
4Colonno RJ,Genovesi EV,Medina I,et al.Long-term entecavir treatment results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection. The Journal of Infectious Diseases . 2001
5ShettyAK,GansHA,SoS,et al.Intravenous ribavirintherapy for adenovirus pneumonia. PediatrPulmonol . 2000
6PerrilloRP,SchalmSW,SchiffER,et al.PredictorsofHBsAg serocnversion in chronic hepatitisB pa-tients treated with lamivudine(abstract). Hepatology . 1999
7Liaw YF,Leung NW,Chang TT,et al.Effects of extended lamivudine therapy in Asian patients with chronic hepatitis B Asia Hepatitis Lamivudine Study Group. Gastroenterology . 2000
9Schiff ER,Heathcote J,Dienstag JL,et al.Improvements in liver histology and cirrhosis with extended lamivudine therapy (abstract). Hepatology . 2000
10Marion PL,Salazar FH,Winters MA,et al.Potent efficacy of entecavir(BMS-200475)in a duck model of hepatitis B virus replication. Antimicrobial Agents and Chemotherapy . 2002
